ODDB.org: Open Drug Database | Drugs

Mepha Pharma AG - Irbesartan-HCT-Mepha 300mg/12.5mg, Filmtabletten

Swissmedic Registration	61497	Sequence	02
Product name	Irbesartan-HCT-Mepha 300mg/12.5mg	Description	Filmtabletten
ATC-Classification	C09DA04	ATC-Description	Irbesartan and Diuretics
Introduction of Sequence	08.02.2011

Composition

irbesartanum 300.0 mg, hydrochlorothiazidum 12.5 mg, povidonum, amylum pregelificatum, poloxamerum 188, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 1.51 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 6000, macrogolum 400, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Hydrochlorothiazide	12.5 mg
Irbesartan	300 mg

BAG: Active Agent	Dose
Hydrochlorothiazide	12.5 mg
Irbesartan	300 mg

Inactive agents	Dose	additional_information






		color.
		color.
Hypromellosum		Überzug
Macrogol	400

Poloxamer	188
Povidone

Silica Colloidalis Anhydrica

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	28 Tablet(s)	12.49	30.00	B	SL	No
004	98 Tablet(s)	43.11	63.30	B	SL	No

2025	©ywesee GmbH